P

Pharmazz

India - Greater Noida
Biotechnology

Focus: Small Molecules

Pharmazz is a life sciences company focused on Small Molecules.

NeurologyRespiratoryCritical Care Medicine
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
1

Pipeline & Clinical Trials

PMZ-2010
Healthy
Phase 1
Clinical Trials (1)
NCT02408731A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers
Phase 1
Normal Saline along with standard treatment
Acute Spinal Cord Injury
Phase 2
Clinical Trials (1)
NCT04054414PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
Phase 2
Normal Saline along with standard treatment
Hypoxic-Ischemic Encephalopathy
Phase 2
Clinical Trials (1)
NCT05514340Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Phase 2
Normal Saline along with standard treatment
Alzheimer Disease
Phase 2
Clinical Trials (1)
NCT04052737PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease
Phase 2
Normal Saline
Hypovolemic Shock
Phase 2
Clinical Trials (1)
NCT04056065PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
Phase 2
Normal Saline along with standard treatment
Acute Stroke
Phase 2
Clinical Trials (1)
NCT04046484PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
Phase 2
Clinical Trials (1)
NCT05241067Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
Phase 2
Normal Saline
Hypovolemic Shock
Phase 3
Clinical Trials (1)
NCT05251181A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Phase 3
Normal Saline along with standard treatment
Cerebral Ischemia
Phase 3
Clinical Trials (1)
NCT04047563Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
Phase 3
Normal saline + Standard Treatment
Hypovolemic Shock
Phase 3
Clinical Trials (1)
NCT04045327Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock
Phase 3
Drug: Normal Saline
Acute Ischemic Stroke
Phase 3
Clinical Trials (1)
NCT05691244Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Phase 3
Phase 4
Clinical Trials (1)
NCT05955326Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Phase 4
Phase 4
Clinical Trials (1)
NCT05956418A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
Phase 4

Open Jobs (1)

Interview Prep Quick Facts
Portfolio: 13 clinical trials
Top TAs: Neurology, Respiratory
Publications: 25 in PubMed
Open Roles: 1 active job
Therapeutic Area Focus
Neurology
4 pipeline
Respiratory
1 pipeline
Marketed
Pipeline